Cargando…

Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation?

Atorvastatin and direct oral factor Xa inhibitors (xabans) are frequently co‐administrated in patients with atrial fibrillation (AF). However, no studies investigating the possibility of the pharmacologic interaction between these agents have been conducted. The aim of this prospective observational...

Descripción completa

Detalles Bibliográficos
Autores principales:	Škorňová, Ingrid, Samoš, Matej, Bolek, Tomáš, Stančiaková, Lucia, Vádelová, Ľubica, Galajda, Peter, Staško, Ján, Kubisz, Peter, Mokáň, Marián
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118196/ https://www.ncbi.nlm.nih.gov/pubmed/33984191 http://dx.doi.org/10.1002/prp2.730

Ejemplares similares

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Viscoelastic Hemostatic Assays and Platelet Function Testing in Patients with Atherosclerotic Vascular Diseases
por: Samoš, Matej, et al.
Publicado: (2021)

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
por: Prídavková, Dana, et al.
Publicado: (2019)

COVID-19 and the Response to Antiplatelet Therapy
por: Bolek, Tomáš, et al.
Publicado: (2023)

How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?
por: Stanciakova, Lucia, et al.
Publicado: (2022)

How Can Rotational Thromboelastometry as a Point-of-Care Method Be Useful for the Management of Secondary Thromboprophylaxis in High-Risk Pregnant Patients?
por: Stanciakova, Lucia, et al.
Publicado: (2021)

The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study
por: Samoš, Matej, et al.
Publicado: (2016)

Role of Thromboelastography and Rotational Thromboelastometry in the Management of Cardiovascular Diseases
por: Korpallová, Barbora, et al.
Publicado: (2018)

Monitoring the hemostasis with rotation thromboelastometry in patients with acute STEMI on dual antiplatelet therapy: First experiences
por: Samoš, Matej, et al.
Publicado: (2017)

Rotational thromboelastometry in patients with type 2 diabetes and mild COVID-19 pneumonia: A pilot prospective study
por: Bolek, Tomáš, et al.
Publicado: (2022)

Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?
por: Blaško, Peter, et al.
Publicado: (2022)

Type 2 Diabetes and ADP Receptor Blocker Therapy
por: Samoš, Matej, et al.
Publicado: (2016)

First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans
por: Nehaj, Frantisek, et al.
Publicado: (2017)

Sticky platelets syndrome in a young patient with massive pulmonary embolism
por: Darulová, Stanislava, et al.
Publicado: (2013)

SARS-CoV-2 Infection-Associated Aortic Thrombosis Treated with Oral Factor Xa Inhibition
por: Strýčková, Alena, et al.
Publicado: (2022)

DNA Polymorphisms in Pregnant Women with Sticky Platelet Syndrome
por: Stančiaková, Lucia, et al.
Publicado: (2022)

A Functional Assay for the Determination of Heparin-Induced Thrombocytopenia via Flow Cytometry
por: Skornova, Ingrid, et al.
Publicado: (2023)

How to Treat Today? Oral and Facial Cancer-Associated Venous Thromboembolism
por: Janíčková, Mária, et al.
Publicado: (2023)

High On-Treatment Platelet Reactivity in Patients Undergoing Complex Percutaneous Coronary Interventions
por: Urban, Lukáš, et al.
Publicado: (2023)

Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy
por: Benko, Jakub, et al.
Publicado: (2022)

Impact of Edoxaban on Thrombin-Dependent Platelet Aggregation
por: Sokol, Juraj, et al.
Publicado: (2020)

The Anti-Thrombotic Effects of PCSK9 Inhibitors
por: Péč, Martin Jozef, et al.
Publicado: (2023)

Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders
por: Simurda, Tomas, et al.
Publicado: (2017)

Heterogeneity of Genotype–Phenotype in Congenital Hypofibrinogenemia—A Review of Case Reports Associated with Bleeding and Thrombosis
por: Brunclikova, Monika, et al.
Publicado: (2022)

Recurrent Ileal Variceal Bleeding as a Diagnostic and Therapeutic Challenge
por: Cingel, Marek, et al.
Publicado: (2022)

Genetic Variants in the FGB and FGG Genes Mapping in the Beta and Gamma Nodules of the Fibrinogen Molecule in Congenital Quantitative Fibrinogen Disorders Associated with a Thrombotic Phenotype
por: Simurda, Tomas, et al.
Publicado: (2020)

Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience
por: Skornova, Ingrid, et al.
Publicado: (2021)

Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management
por: Simurda, Tomas, et al.
Publicado: (2021)

A Novel Nonsense Mutation in FGB (c.1421G>A; p.Trp474Ter) in the Beta Chain of Fibrinogen Causing Hypofibrinogenemia with Bleeding Phenotype
por: Simurda, Tomas, et al.
Publicado: (2020)

EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non‐valvular atrial fibrillation in clinical practice Setting in France, rationale and design of the NAXOS: SNIIRAM study
por: Picard, Fabien, et al.
Publicado: (2019)

Insulinoma presenting with postprandial hypoglycemia and a low body mass index: A case report
por: Prídavková, Dana, et al.
Publicado: (2020)

The ReInforcement of adherence via self-monitoring app orchestrating biosignals and medication of RivaroXaban in patients with atrial fibrillation and co-morbidities: a study protocol for a randomized controlled trial (RIVOX-AF)
por: Yoon, Minjae, et al.
Publicado: (2023)

ENGAGE AF: Effective anticoagulation with factor Xa in next generation treatment of atrial fibrillation
por: Kaba, Riyaz A, et al.
Publicado: (2013)

Ischemic stroke and dose adjustment of oral Factor Xa inhibitors in patients with atrial fibrillation
por: Stoll, Svenja, et al.
Publicado: (2020)

Effects of atorvastatin on atrial remodeling in a rabbit model of atrial fibrillation produced by rapid atrial pacing
por: Yang, Qian, et al.
Publicado: (2016)

Glycoprotein VI Gene Variants Affect Pregnancy Loss in Patients With Platelet Hyperaggregability
por: Sokol, Juraj, et al.
Publicado: (2018)

Successful immune tolerance induction consisting of high-dose factor VIII rich in von Willebrand factor and pulsed intravenous immunoglobulin: a case report
por: Kubisz, Peter, et al.
Publicado: (2012)

Basic Principles of Rotational Thromboelastometry (ROTEM(®)) and the Role of ROTEM—Guided Fibrinogen Replacement Therapy in the Management of Coagulopathies
por: Drotarova, Miroslava, et al.
Publicado: (2023)

The preventive effect of atorvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials
por: Yang, Qian, et al.
Publicado: (2014)

Impact of Dabigatran Treatment on Rotation Thromboelastometry
por: Sokol, Juraj, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9199vrdjpp3jgkdrq5ldrcr20q